After years of weight loss drug shortages, the FDA is saying there's now an adequate supply for most medications and they ...

To conduct the study, authors used Google Shopping to search for websites advertising prescriptions for, or the sale of, compounded semaglutide, tirzepatide, and/or liraglutide (the active ...

The FDA authorizes companies to offer compounded versions of GLP-1s and ... offerings such as oral-based weight loss medications and liraglutide, another GLP-1 injection drug.

Compounded drugs use the same active ingredients ... dulaglutide injections sold under the brand name Trulicity and some liraglutide injections – remain in shortage. CNN’s Meg Tirrell ...

Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn’t guarantee it would be able to continue ...

On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 ...

Telehealth company Hims & Hers Health (HIMS) witnessed a major dip in its stock recently despite reporting 95% revenue growth ...

As availability evolves, we are prepared to support members with alternative options, including FDA-approved, branded GLP-1s and other compounded medications like liraglutide (a GLP-1 injection ...